Patent · US Active

Anti-Axl antagonistic antibodies

US11198734B2 · kind B2 · utility

2Cited by
3References
31Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 21, 2017
Grant dateDec 14, 2021
Priority date
Expiry dateJul 24, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to antibodies that specifically bind a novel epitope on the AxI protein. Also disclosed are methods for the production and use of the anti-Axl antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.